Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)

v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenues, net $ 13,217 $ 29,092 $ 32,520 $ 76,623
Cost of revenues 6,769 10,372 15,552 29,226
Gross profit 6,448 18,720 16,968 47,397
Operating expenses:        
Diagnostic expenses 597 1,799 1,800 6,471
General and administration 9,937 6,306 18,235 14,130
Research and development 572 28 716 63
Total operating expenses 11,106 8,133 20,751 20,664
(Loss) income from operations (4,658) 10,587 (3,783) 26,733
Interest income, net 27 25 38 98
Interest expense (291) (201) (506) (434)
Change in fair value of investment securities 0 0 0 (76)
Other income (loss) 8 0 (99) 0
(Loss) income from operations before income taxes (4,914) 10,411 (4,350) 26,321
Income tax benefit (expense) 1,474 (2,965) 1,460 (6,381)
(Loss) income from operations after income taxes (3,440) 7,446 (2,890) 19,940
Net (loss) income (3,440) 7,446 (2,890) 19,940
Other comprehensive (loss) income:        
Unrealized gain (loss) on marketable debt securities 496 (98) (169) (61)
Total comprehensive (loss) income $ (2,944) $ 7,348 $ (3,059) $ 19,879
Earnings per share:        
Earnings (loss) per share, basic (in dollars per share) $ (0.20) $ 0.48 $ (0.17) $ 1.28
Earnings (loss) per share, diluted (in dollars per share) $ (0.20) $ 0.40 $ (0.17) $ 1.07
Weighted average common shares outstanding:        
Weighted average common shares outstanding, basic (in shares) 16,845 15,576 16,797 15,531
Weighted average common shares outstanding, diluted (in shares) 16,845 19,272 16,797 18,964